Total Payments
$1,155
2024 Payments
$43.53
Companies
6
Transactions
89
Medicare Patients
1,911
Medicare Billing
$234,750
Payment Breakdown by Category
Food & Beverage$1,026 (88.8%)
Education$129.49 (11.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,026 | 87 | 88.8% |
| Education | $129.49 | 2 | 11.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $368.05 | 28 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $343.49 | 28 | $0 (2024) |
| AbbVie Inc. | $250.71 | 26 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $169.34 | 5 | $0 (2019) |
| Corium, LLC | $12.19 | 1 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $11.32 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.53 | 3 | Teva Pharmaceuticals USA, Inc. ($31.34) |
| 2023 | $27.48 | 1 | AbbVie Inc. ($27.48) |
| 2021 | $234.55 | 26 | AbbVie Inc. ($223.23) |
| 2020 | $185.68 | 8 | Teva Pharmaceuticals USA, Inc. ($173.57) |
| 2019 | $163.39 | 21 | Teva Pharmaceuticals USA, Inc. ($138.58) |
| 2018 | $172.21 | 8 | Allergan Inc. ($124.28) |
| 2017 | $328.26 | 22 | Allergan Inc. ($231.66) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Central Nervous System | ||||||
| 09/30/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Central Nervous System | ||||||
| 02/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.65 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $11.32 | General |
| Category: PSYCHOLOGY | ||||||
| 11/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $0.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 441 | 1,117 | $123,120 | $56,569 |
| 2022 | 5 | 457 | 1,233 | $129,580 | $53,398 |
| 2021 | 6 | 547 | 1,531 | $160,120 | $67,179 |
| 2020 | 7 | 466 | 1,444 | $144,795 | $57,605 |
Total Patients
1,911
Total Services
5,325
Medicare Billing
$234,750
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 139 | 468 | $42,630 | $19,006 | 44.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 143 | 143 | $30,235 | $13,735 | 45.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 56 | 302 | $24,505 | $11,355 | 46.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 112 | $10,040 | $6,750 | 67.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 59 | 70 | $12,365 | $4,442 | 35.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 22 | $3,345 | $1,280 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 496 | $44,640 | $19,226 | 43.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 83 | 508 | $40,640 | $15,049 | 37.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 140 | 140 | $29,400 | $12,994 | 44.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 55 | 62 | $10,850 | $4,657 | 42.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 25 | 27 | $4,050 | $1,472 | 36.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 165 | 540 | $48,600 | $21,764 | 44.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 103 | 691 | $55,280 | $20,418 | 36.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 169 | 169 | $35,490 | $16,046 | 45.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 57 | 72 | $12,600 | $5,449 | 43.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 42 | 45 | $6,750 | $2,442 | 36.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 14 | $1,400 | $1,059 | 75.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 92 | 657 | $52,560 | $20,177 | 38.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 168 | 569 | $51,210 | $17,889 | 34.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 130 | 130 | $27,300 | $13,575 | 49.7% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 25 | 33 | $5,775 | $2,543 | 44.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 24 | 27 | $4,050 | $1,542 | 38.1% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2020 | 11 | 11 | $2,200 | $983.29 | 44.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 17 | $1,700 | $897.02 | 52.8% |
About Dr. Safiullah Syed, MD
Dr. Safiullah Syed, MD is a Psychiatry healthcare provider based in Beckley, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376629592.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Safiullah Syed, MD has received a total of $1,155 in payments from pharmaceutical and medical device companies, with $43.53 received in 2024. These payments were reported across 89 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,026).
As a Medicare-enrolled provider, Syed has provided services to 1,911 Medicare beneficiaries, totaling 5,325 services with total Medicare billing of $234,750. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Beckley, WV
- Active Since 10/31/2006
- Last Updated 08/02/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1376629592
Products in Payments
- VRAYLAR (Drug) $588.03
- AUSTEDO (Drug) $214.16
- LATUDA (Drug) $169.34
- Austedo XR (Drug) $31.34
- VIIBRYD (Drug) $15.78
- NAMZARIC (Drug) $14.95
- Azstarys (Drug) $12.19
- QELBREE (Drug) $11.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Beckley
Dr. Ahmed Faheem, Md, MD
Psychiatry — Payments: $122,820
Psychiatry $122,820
Dr. Omar Hasan, Md, MD
Psychiatry — Payments: $44,378
Psychiatry $44,378
Hassan Jafary, Md, MD
Psychiatry — Payments: $17,454
Psychiatry $17,454
Dr. Jawad Zafar, D.o, D.O
Psychiatry — Payments: $8,608
Psychiatry $8,608
Michelle Bez, Pa-C, PA-C
Psychiatry — Payments: $4,373
Psychiatry $4,373
Dr. Brandon Workman, D.o, D.O
Psychiatry — Payments: $3,431
Psychiatry $3,431